2-Ethylhexanoic Acid

2-Ethylhexanoic Acid

SCHEMBL39267

CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Nb+3]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.91
MAPK1 P28482 1/20 0.61
CA1 P00915 7/20 0.59
CYP3A4 P08684 2/20 0.56
TSHR P16473 2/20 0.56
NFKB1 P19838 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
USP2 O75604 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Ethylhexanoic Acid SCHEMBL2400572 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL56210 0.95 CA2 (1.00) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL546693 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL1506922 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL1962834 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL23802667 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL7174090 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL20582677 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL21569275 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR
2-Ethylhexanoic Acid SCHEMBL305226 0.95 CA2 (0.91) CA2MAPK1CA1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212690-A1 PIEZOELECTRIC ELEMENT, LIQUID EJECTION HEAD, AND PRINTER SEIKO EPSON CORPORATION (JP) 2025-06-26 US claimed
CN-116750809-A Modified ternary positive electrode material and preparation method thereof 新乡天力锂能股份有限公司 2023-09-15 CN claimed
EP-2563734-B1 A METHOD OF DEPOSITING NIOBIUM DOPED TITANIA FILM ON A SUBSTRATE AND THE COATED SUBSTRATE MADE THEREBY VITRO SAB DE CV (MX) 2019-08-21 EP claimed
US-20180108457-A1 Method of Depositing Niobium Doped Titania Film on a Substrate and the Coated Substrate Made Thereby VITRO FLAT GLASS LLC 2018-04-19 US claimed
US-20140037988-A1 METHOD OF DEPOSITING NIOBIUM DOPED TITANIA FILM ON A SUBSTRATE AND THE COATED SUBSTRATE MADE THEREBY PPG INDUSTRIES OHIO, INC. (US) 2014-02-06 US claimed
EP-2563734-A2 A METHOD OF DEPOSITING NIOBIUM DOPED TITANIA FILM ON A SUBSTRATE AND THE COATED SUBSTRATE MADE THEREBY PPG Industries Ohio, Inc. (US) 2013-03-06 EP claimed
WO-2011139523-A2 A METHOD OF DEPOSITING NIOBIUM DOPED TITANIA FILM ON A SUBSTRATE AND THE COATED SUBSTRATE MADE THEREBY PPG INDUSTRIES OHIO, INC. (US) 2011-11-10 WO claimed
US-20110262757-A1 METHOD OF DEPOSITING NIOBIUM DOPED TITANIA FILM ON A SUBSTRATE AND THE COATED SUBSTRATE MADE THEREBY PPG INDUSTRIES OHIO, INC. (US) 2011-10-27 US claimed
US-20100159128-A1 Niobium 2-ethylhexanoate derivative, method of producing the derivative, organic acid metal salt composition containing the derivative, and method of producing thin film using the composition YOSHINAKA ATSUYA 2010-06-24 US claimed
US-20090136658-A1 Niobium 2-Ethylhexanoate Derivative, Method Of Producing The Derivative, Organic Acid Metal Salt Composition Containing The Derivative, And Method Of Producing Thin Film Using The Composition ADEKA CORPORATION (JP) 2009-05-28 US claimed
US-6686489-B2 Metal organic precursors for transparent metal oxide thin films and method of making same SYMETRIX CORPORATION 2004-02-03 US claimed
US-20020087018-A1 Metal organic precursors for transparent metal oxide thin films and method of making same SYMETRIX CORPORATION 2002-07-04 US claimed
US-20260143970-A1 PIEZOELECTRIC ELEMENT, LIQUID EJECTION HEAD, AND LIQUID EJECTION APPARATUS SEIKO EPSON CORP (JP) 2026-05-21 US disclosed
CN-122054911-A Piezoelectric element, liquid discharge head, and liquid discharge apparatus 精工爱普生株式会社 2026-05-15 CN disclosed
EP-4429445-B1 PIEZOELECTRIC ELEMENT APPLICATION DEVICE SEIKO EPSON CORP (JP) 2026-04-15 EP disclosed
US-20260060004-A1 PIEZOELECTRIC ELEMENT, LIQUID EJECTION HEAD, AND PRINTER SEIKO EPSON CORP (JP) 2026-02-26 US disclosed
EP-0665981-A1 PROCESS FOR FABRICATING LAYERED SUPERLATTICE MATERIALS AND MAKING ELECTRONIC DEVICES INCLUDING SAME SYMETRIX CORPORATION (US) 1995-08-09 EP disclosed
US-5439845-A Process for fabricating layered superlattice materials and making electronic devices including same OLYMPUS OPTICAL CO., LTD. (JP) 1995-08-08 US disclosed
US-5434102-A Integrated circuits SYMETRIX CORPORATION (US) 1995-07-18 US disclosed
WO-1994010702-A1 PROCESS FOR FABRICATING LAYERED SUPERLATTICE MATERIALS AND MAKING ELECTRONIC DEVICES INCLUDING SAME SYMETRIX CORPORATION (US) 1994-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136658-A1 Niobium 2-Ethylhexanoate Derivative, Method Of Producing The Derivative, Organic Acid Metal Salt Composition Containing The Derivative, And Method Of Producing Thin Film Using The Composition HDHD5, HAO2, CA2 CA2 3/4885MAPK1 2383/4885CA1 80/4885
US-20260143970-A1 PIEZOELECTRIC ELEMENT, LIQUID EJECTION HEAD, AND LIQUID EJECTION APPARATUS HCN4, HCN2, KCNJ2 CA2 228/4885MAPK1 1635/4885CA1 237/4885
US-20260060004-A1 PIEZOELECTRIC ELEMENT, LIQUID EJECTION HEAD, AND PRINTER HCN4, EPCAM, SLC9A2 CA2 1257/4885MAPK1 1337/4885CA1 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.